ZHANG Yan, GAO Shan, YANG Dan, PAN Yanfei, JIANG Shuyan. Effect of single disease nursing quality standards on blood glucose, compliance and self-management ability in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2017, (6): 45-48. DOI: 10.7619/jcmp.201706014
Citation: ZHANG Yan, GAO Shan, YANG Dan, PAN Yanfei, JIANG Shuyan. Effect of single disease nursing quality standards on blood glucose, compliance and self-management ability in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2017, (6): 45-48. DOI: 10.7619/jcmp.201706014

Effect of single disease nursing quality standards on blood glucose, compliance and self-management ability in patients with type 2 diabetes mellitus

More Information
  • Objective To explore the effect of single disease nursing quality standards on blood glucose,compliance and self-management ability in patients with type 2 diabetes mellitus.Methods A total of 434 type 2 diabetes cases in hospital were randomly divided into control group and observation group,with 217 cases in each group,given holistic nursing and health education as well as nursing quality standards.Nursing measures,and health education were implemented and nursing effect was evaluated.Results The observation group had better treatment compliance,standardization rate of blood sugar and self-management ability,and lower incidence rate of hypoglycemia than that the control group (P < 0.05).Conclusion Standards of single disease nursing quality can greatly improve treatment compliance,self-management ability and standardization rate of blood sugar in patients with diabetes,reduce the incidence of low blood sugar,prevent acute and chronic complications occurrence.
  • Related Articles

    [1]ZHANG Lanfang, CHEN Xu, KUAI Jun, QIN Lei, YANG Yan, CHANG Tingmin. Effect of tegafur, gimeracil and oteracil potassium combined with oxaliplatin on gastric motility-related hormones, matrix metalloproteinase-2 and matrix metalloproteinase-9 in elderly patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(12): 57-60, 65. DOI: 10.7619/jcmp.20241047
    [2]ZHENG Leizhen, LIU Xianli. Comparison in efficacy of neoadjuvant chemotherapies combined with surgery for advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 26-29. DOI: 10.7619/jcmp.20201637
    [3]ZHOU Wei, CHEN Quanquan, LUO Hongmei. Efficacy and safety of XELOX and FOLFOX4 regimens in the treatment of patients with advanced gastric carcinoma[J]. Journal of Clinical Medicine in Practice, 2016, (9): 64-66. DOI: 10.7619/jcmp.201609018
    [4]ZHANG Songzhen, XUE Qiaoyun, CHENG Shuying. Effect of shenqi fuzheng injection on immune function of patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2016, (7): 48-51. DOI: 10.7619/jcmp.201607014
    [5]CHENG Xiaofei. Clinical research on TGOPC combined with docetaxel and platinum in treatment of patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2015, (19): 22-25. DOI: 10.7619/jcmp.201519007
    [6]Efficacy and safety of TOF and SOX regimens in the treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2013, (21): 66-68,76. DOI: 10.7619/jcmp.201321018
    [7]ZHANG Chunlin, ZHAO Lin. Clinical application of neoadjuvant therapy in advanced gastric cancer and its effect on prognosis[J]. Journal of Clinical Medicine in Practice, 2013, (21): 46-49. DOI: 10.7619/jcmp.201321013
    [8]ZHUANG Min, ZHANG Wei-min, LIU Xiao-qing. The clinical study of domestic compound Tegafur capsulecombined with Paclitaxel second-line therapy for patients with advanced or metastatic gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (15): 94-96. DOI: 10.3969/j.issn.1672-2353.2011.15.034
    [9]ZHAO Xiao-guang, ZHANG Yan-zhu. Clinical investigation of S-1 alone in the treatment of elderly patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (11): 103-105. DOI: 10.3969/j.issn.1672-2353.2011.11.036
    [10]WANG Si-liang, CHEN Xiao-dong, WU Rong, QIAN Hao-chu. Clinical observation of Docetaxel combined with FOLFOX on advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (9): 59-61. DOI: 10.3969/j.issn.1672-2353.2011.09.019

Catalog

    Article views (336) PDF downloads (6) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return